A large twin-cohort study finds no meaningful academic disadvantage for children with atopic dermatitis.
Children with atopic dermatitis are not at risk of meaningful academic underperformance at the point of national examinations, according to a large, population-based analysis spanning nearly 800,000 students in England and Denmark.
The findings, published in JAMA Dermatology, challenge long-held concerns about the educational impact of chronic inflammatory skin disease.
The researchers reported that adolescents with atopic dermatitis achieved comparable final compulsory exam outcomes to their peers without the condition, with only negligible differences in grade averages and pass rates once socioeconomic and clinical factors were accounted for.
“AD does not appear to impair academic performance; the findings provide reassurance for children living with AD and their families as well as teachers and clinicians,” the researchers wrote.
The study drew on two longitudinal cohorts with complementary designs, including a Danish nationwide registry data following children born between 1986 and 2000, and the Avon Longitudinal Study of Parents and Children in England.
Across both settings, investigators assessed performance at around age 16 years, using standardised national examinations, analysing both binary outcomes such as non-passing grades and continuous academic scores.
In Denmark, where more than 776,000 students were included, the prevalence of non-passing grades was 12.0% among those with atopic dermatitis compared with 11.2% in those without, a difference that translated into only a marginal adjusted effect.
Mean grade differences were similarly small, amounting to a −0.06-point difference on a scale ranging from −3 to 12.
Related
In England, outcomes were directionally favourable for children with atopic dermatitis, who had lower rates of non-passing grades and modestly higher mean scores, though the authors cautioned that these findings likely reflected residual confounding rather than a true protective effect.
The analyses accounted for disease phenotype, severity and socioeconomic background, and showed no consistent pattern suggesting that particular subgroups were disadvantaged.
Even in sibling-comparison models designed to control for shared familial and environmental factors, results remained stable, reinforcing the conclusion that atopic dermatitis itself is unlikely to exert a clinically meaningful effect on academic attainment.
The findings address a persistent concern among clinicians that symptoms such as pruritus, sleep disturbance and psychosocial stress might impair concentration and learning.
While the study did observe a slightly higher rate of non-passing grades among children with active disease in Denmark, this was not replicated across settings or outcome measures and did not follow a dose–response pattern, weakening any causal interpretation.
“The parallel studies’ results are reassuring for clinicians, educators and families, and do not support routine expectations of academic underperformance due to AD among adolescents taking national compulsory examinations,” the researchers concluded.
“Nevertheless, because children with AD may experience symptoms interfering with concentration, sleep, or participation, a tailored, needs-based approach remains important to improve quality of life.”
